Brief: FDA Approves New Antibiotic For Three Different Uses

Basilea Pharmaceutica AG, Allschwil

03/04/2024 20:33

April 3 (Reuters) - FDA:
    * FDA APPROVES NEW ANTIBIOTIC FOR THREE DIFFERENT USES
    * FDA SAYS APPROVED ZEVTERA (CEFTOBIPROLE MEDOCARIL SODIUM
FOR
INJECTION) FOR THE TREATMENT OF ADULTS WITH STAPHYLOCOCCUS
AUREUS BLOODSTREAM INFECTIONS
    * FDA SAYS GRANTED THE APPROVAL OF ZEVTERA TO BASILEA
PHARMACEUTICA INTERNATIONAL LTD.
    * FDA SAYS APPROVED ZEVTERA FOR THE TREATMENT OF ADULTS WITH
ACUTE
BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS
    * FDA SAYS APPROVED ZEVTERA FOR TREATMENT OF PEDIATRIC
PATIENTS
THREE MONTHS TO LESS THAN 18 YEARS OLD WITH COMMUNITY-ACQUIRED
BACTERIAL PNEUMONIA


 ((Reuters.Briefs@thomsonreuters.com;))